Therapeutic implications of the gender-specific aspects of cardiovascular disease

  • Regitz-Zagrosek V
  • 68


    Mendeley users who have this article in their library.
  • 160


    Citations of this article.


The manifestations of cardiovascular diseases differ between men and women, as do outcomes after therapeutic interventions. It is important that those involved in drug discovery and development, as well as disease treatment, are aware of these differences because such variations are likely to have an increasing role in therapeutic decisions in the future. Here, I review gender differences in the most frequent cardiovascular diseases and their underlying sex-dependent molecular pathophysiology, and discuss gender-specific effects of current cardiovascular drugs and the implications for novel strategies for drug development.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Vera Regitz-Zagrosek

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free